Endogenex retweeted
Mayo Clinic researchers are seeking volunteers ages 22-70 with a BMI between 27-40 for a randomized study of a device used for the treatment of type 2 diabetes. Contact [email protected] or visit mayocl.in/40Tvhul for information.
Endogenex retweeted
A new paradigm suggesting that the integrative function of the duodenum in orchestrating the metabolic response is altered in metabolic diseases due to inflammation. This could represent a novel, potentially disease-modifying therapeutic target for type II diabetes. #diabetes2 #duodenum
Have you heard of diabetic duodenopathy? This refers to endoscopic and histological changes in the duodenum as a metabolic adaptation to diabetes. Look out for it! Courtesy of @babudayyeh @ESGE_news
Endogenex retweeted
Replying to @babudayyeh
@babudayyeh presenting cutting-edge data on endoscopic therapy approaches to #diabetes management
A glimpse into the future!
@DDWMeeting #DDW2024
Endogenex retweeted
Geoff Pardo and Stacey Pugh talk about Stacey’s career that began at the bedside as a trauma nurse and is now leading the charge at @Endogenex to take a new approach to Type 2 Diabetes treatment. Listen to the conversation: medtechmvp.com/media/medtech…
Endogenex retweeted
#Endogenex, developer of a procedure for treating type 2 #diabetes, announced today that it appointed Stacey Pugh as its new CEO.
More from @endogenex, HERE: drugdeliverybusiness.com/end…
#Surgical #Finance










